VIA Screen-and-Treat Cervical Cancer Prevention in Guyana: A Mobile Clinic Pilot Project to a Remote Amerindian Community John E. Varallo, MD, MPH, FACOG.

Slides:



Advertisements
Similar presentations
UICC HPV and Cervical Cancer Curriculum Table of contents UICC HPV and CERVICAL CANCER CURRICULUM.
Advertisements

Demographic and clinical characteristics associated with timely utilization of cervical cancer prevention services for women enrolled in comprehensive.
Maternal and Reproductive Health Issues in Uganda Miriam Nakalembe, MD OB/GYN, Makerere University, Kampala, Uganda Global Health Lecture Series, Lubbock,
Repositioning Prevention and Control of Cancers of Reproductive Organs in Kenya Repositioning Prevention and Control of Cancers of Reproductive Organs.
Harshad Sanghvi Medical Director, JHPIEGO
Italian Cervical Screening Programme. 17ème congrés de la Société Marocaine de Cancerologie Avril, Marrakech Marco Zappa ISPO, Scientific Institute.
Ahimsa Fund 20 rue Ernest Fabrègue Lyon – France Screening for cervical cancer in Burundi Dr. Françoise Baylet-Vincent, Pathologist.
Treatment Options for CIN Cervical Cancer screening is designed to detect CIN If CIN is present treatment should theoretically avoid subsequent cancer.
Overview  Launched in 2011, PRRR is a partnership of public and private organizations with a shared goal of reducing deaths from cervical and breast.
ACCP Evidence base: Implications for policy and practice R. Sankaranarayanan MD Head, Screening Group World Health Organization (WHO) International Agency.
UNVEILLING OF ISAAC FOLORUNSO ADEWOLE FOUNDATION (IFAF)
Cost-Effectiveness of Cervical Cancer Screening Strategies: Examples from Different World Regions Jane J. Kim, Ph.D. Sue J. Goldie, M.D., M.P.H. Harvard.
HPV and cervical screening Test of cure
PEPFAR An Integrated Mobile Model Reaching Women in Remote Areas of Zambia by Building on HIV/AIDS Platforms for Cervical Cancer Services Delivery July.
Cervical Cancer and HIV: Interactions and Interventions Jean R. Anderson, M.D. Jhpiego, an affiliate of Johns Hopkins University The Johns Hopkins University.
Cervical cancer screening in Estonia: present situation Piret Veerus Department of Epidemiology and Biostatistics National Institute for Health Development.
Cervical cancer screening problems and barriers in Latvia
Cancer Prevention in Taiwan
MINISTRY OF HEALTH Cervical Cancer in Kenya Presentation to the Cancer workshop – KNH 13 th April 2012 Dr Nancy Kidula.
PROJECT Situation analysis and cost- effectiveness analysis of cervical cancer screening in Russia Coordinator of the project: N. Koroleva.
Well Women in Northern Haiti Featured program for April 2015 MamaBaby Haiti.
ZIMBABWE AIDS CARE FOUNDATION NEWLANDS CLINIC Is Cervical Cancer Screening a necessary part of HIV care in Zimbabwe? ZIMA Congress Friday 29 th August.
Seeing is Believing: VIA and the Single-Visit- Approach to Cervical Cancer Prevention Dr. John E. Varallo - Senior Technical Advisor Heather Harrison -
Screening for Cervical Cancer by Visual Inspection Techniques Dr Aruna Batra VMMC & SJH.
Ahimsa Fund 20 rue Ernest Fabrègue Lyon – France Marlène CASTILLOUX Cytologist Québec, Canada Dr. Chantal DONNE Pathologist Lyon,
Trial of liquid chlorine dispenser models in urban Bangladeshi households Shaila Arman Research Investigator Water and Sanitation Research Group Center.
UNFPA - Delhi MATERNAL DEATH CAN AND SHOULD BE PREVENTED By Francois M. Farah UNFPA REDEFINING PREGNANCY AND CHILDBIRTH FROM A RISK MANAGEMENT.
Lecture Thirteen Biomedical Engineering for Global Health.
An Overview of Cervical Cancer jfsdfkjsdlfjhs Naomi Brewer The Future of Cancer Screening in New Zealand Balancing the benefits and risks Auckland, 7 August.
Screening for cervical cancer. Screening for cervical lesions Common disease Cancer is preventable Screening is easy MUST BE PERFORMED.
HPV VACCINATION Dr Frida Mghamba 2 nd East Africa WE CAN Summit 11 th September 2014.
Cervical cancer screening: problems and barriers in Estonia Piret Veerus Department of Epidemiology and Biostatistics National Institute for Health Development.
Cervix Cancer Screening Evolving a New Methodology A Life Saving Initiative of the Chennai Corporation Rajesh Lakhani IAS.
Cervical Cancer By: Kate DeCaro & Brianna Milillo.
Integration of HIV/AIDS and Cervical Cancer Programs for Improved Health Outcomes in Tanzania Dr. January Zilabumba IMA World Health 30 November, 2015.
Sheffield Gynaecological Cancer CentreSheffield Teaching Hospitals PRIMARY HPV SCREENING A view from colposcopy John Tidy Consultant Gynaecological Oncologist.
Proposal by Basic Health International, Inc..  NGO founded by Dr. Miriam Cremer, MD MPH at Mount Sinai School of Medicine, New York City.  Our Vision:
1 April 2010 Jhpiego/Baltimore Veronica Reis, MD, MPH MCHIP Technical Director MAPUTO, MOZAMBIQUE BREAST AND CERVICAL CANCER PREVENTION ACTIVITIES INTEGRATED.
Mary Rose Giattas Marya Plotkin Giulia Besana Maryjane Lacoste Safina Yuma Robert Kamala Mainza Lukobo-Durrell Megan Wysong Harris Sharon Kibwana Kelly.
Honduran Health Alliance What: Women’s Healthcare and Education When: annually in July Where: Southern Honduras Since when? Started in 2003, annual trips.
Malaria is a highly prevalent disease in the tropics million clinical cases million deaths globally each year The World Health Organization.
Acceptability Survey of HPV Vaccine Among Female Sex Workers in Lima, Peru Brandon Brown 1, Cesar Carcamo 2, Maria Valderrama 2, Magaly Blas 2, and Neal.
Cervical Cancer Screening and Treatment at Malamulo Hospital in Rural Malawi: A two-year comprehensive review Crischelle Shank, MD; Jacqueline Uy, MD;
Cervical Cancer How We Can Prevent It Dr Quek Swee Chong Himalayan Women’s Health Project 30 August 2014.
Cervical Cancer: Experiences from a Cohort of HIV-infected Women Pascoe M, Magure T, Mudhokwani P et al Abstract: MOAB0202.
CANCER OF THE CERVIX SCREENING AND EARLY TREATMENT Dr Nelly R. Mugo MBchB, MMED, MPH Dr Rose J. Kosgei MBchB, MMED, Msc Kenyatta National Hospital: Department.
Collaboration with Community Partners to Provide Breast and Cervical Cancer Services to the Underserved University of Texas Health Sciences Center at Tyler.
CERVICAL CANCER PREVENTION STRATEGIES Z Mike Chirenje MD FRCOG Department of Obstetrics and Gynaecology University of Zimbabwe, Harare Zimbabwe
Morphologic Pap Test Findings in HPV Negative Women Age 30 Years and Older: What Information Will Be Lost with HPV Only Primary Screening? Brooke Henninger,
COLLABORATION WITH COMMUNITY PARTNERS TO PROVIDE BREAST AND CERVICAL CANCER SERVICES TO THE UNDERSERVED Patti Olusola, M.D. 1, Sarah Low, M.D. 1, Michelle.
#AIDS2016 Cervical Cancer Prevention in Africa: The Future Nelly Yatich, DrPH University of California San Francisco July 19 th, 2016.
Cervical cancer screening and treatment among HIV+ women in Cambodia: feasible and high yielding M.-E. Raguenaud 1, P. Isaakidis 1, S.A. Khim 1, C. Ping.
Public Health England leads the NHS Screening Programmes
Cancer prevention and early detection
Cancer prevention and early detection
Cancer prevention and early detection
Cancer prevention and early detection
University of Rajarata.
INTRODUCTION: CERVICAL CANCER SCREENING
Treatment Options for Cervical Cancer in Low Income Countries
Cancer prevention and early detection
Cervical Cancer prevention among women in Vlora city: the influence of fear-related to possible positive outcomes Authors: 1*Fatjona Kamberi RN, MSN,
Obstetrician and Gynecologist Malawi Inaugural Cancer Symposium
Hoa Nguyen Lam, Huyen Suong Ho Thi et al.
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Biomedical Engineering for Global Health
Public Health England leads the NHS Screening Programmes
Screening to Prevent Invasive Cervical Cancer (Resource-Stratified)
Epidemiology of cervical cancer in India: Where do we stand today
Presentation transcript:

VIA Screen-and-Treat Cervical Cancer Prevention in Guyana: A Mobile Clinic Pilot Project to a Remote Amerindian Community John E. Varallo, MD, MPH, FACOG - Omni Med, Waban, MA; and Orrin Liddell, MBBS - Dept. of Obstetrics and Gynaecology, Georgetown Public Hospital Corporation, Georgetown, Guyana Main reasons for such high cervical cancer rates 1.Major logistical and technical barriers associated with traditional, multistep, cytology-based screening, such as: Poor access to screening and treatment services Poor linkage of screening with treatment Limited cytopathology services 2. Sociocultural, behavioral, and HPV issues To assess the feasibility, accuracy, safety, and acceptability of performing visual inspection with acetic acid (VIA) with same-day treatment in a mobile clinic to a remote Amerindian community in Guyana A two day cross-sectional study of women living in and around Moruca, an Amerindian village in the remote interior of Guyana. Except for the lead author, all mobile clinic personnel were Guyanese. Team members were trained/supervised by the lead author. All necessary equipment and supplies were transported to the remote clinic site by the mobile clinic team. VIA screening was conducted in the mornings, following a strict protocol. Screen-positive women were treated the same afternoon as their screening. Treatment consisted of Loop Electrosurgical Excision Procedure (LEEP). Tissue specimens were processed at Guyana’s main referral laboratory. Training at main public hospital Travel to interior via multiple boat trips up rivers Moruca - main street/boat launch Mobile clinic waiting area 1.An evidence-based alternative approach to cytological (Pap smears) cervical cancer screening (2, 3, 4, 5). Safe, effective, feasible and sustainable in low-resource settings 2.Relatively simple technique: Clean cervix with 3-5% acetic acid solution (white vinegar) After one minute, visualize cervix with unaided eye - abnormal areas turn whitish. 3.Provides immediate results, allowing immediate treatment or triage. NegativePositive Photo source: JHPIEGO References 1.Ferlay, J, (2004) “Globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide”, Descriptive Epidemiology Group, IARC, Lyon, France. Available at: (Last accessed: Sept., 2006) 2.Alliance for Cervical Cancer Prevention (2004) The Case for Investing in Cervical Cancer Prevention: Cervical Cancer Prevention Issues in Depth, No. 3, ACCP, Seattle, WA 3.Ashford, L, Collymore, Y (2004) Preventing Cervical Cancer Worldwide, Population Reference Bureau, Washington, DC 4.Sankaranarayanan, R, Gaffikin, L, Jacob, M, et al. (2005), “A critical assessment of screening methods for cervical neoplasia”, International Journal of Gynecology & Obstetrics, vol. 89, pp. S Goldie, SJ, Kuhn, L, Denny, L, et al. (2001), “Policy analysis of cervical cancer screening strategies in low resource settings: clinical benefits and cost- effectiveness”, JAMA, vol. 285, pp Varallo, J, Liddell, O (2005), “Visual inspection with acetic acid as an alternative to pap smears for cervical cancer screening in Guyana”, Guyana Health Information Digest, vol. 6 (2), pp High VIA screen-positive rate in this population at 37.5% (27/72), compared to a previous study that revealed a 17% VIA screen-positive rate in the capital city of Georgetown (6). Immediate Results  % of women who received immediate results following VIA 100% (72/72)* Promotes Linkage with Treatment  % of VIA screen-positive women who received same-day treatment 100% (27/27) Accurate  % of VIA screen-positive women with cervical dysplasia on histopathology of LEEP specimens 93% (25/27) Safe  % of women experiencing significant complications following screening/treatment 0% (0/72) Acceptable  % of women who reported satisfaction or high satisfaction with services and would recommend other women to participate in future prevention services 100% (72/72) *In comparison, another study revealed that only 28% (27/95) of women received pap smear results or had them recorded in their charts 6 months after screening (6). Cervical cancer prevention using VIA combined with same-day treatment in a mobile clinic in Guyana is feasible, accurate, safe, and highly acceptable. This low-cost strategy is a practical alternative to dramatically expand coverage of cervical cancer prevention services in settings such as Guyana. A national policy for cervical cancer prevention based on this model (using both Cryotherapy and LEEP for treatment) has been accepted in principal. HPV typing and possible vaccination are being considered for incorporation into the national policy. Acknowledgements The authors would like to thank the following for their continued support and encouragement: Dr. Ed O’Neil and Omni Med; Dr. Madan Rambaran and Georgetown Public Hospital Corporation; Dr. Leslie Ramsammy, Sonya Roopnauth and the Ministry of Health; and Patricia Singh and the Regional Health Services. Guyana suffers among the highest cervical cancer rates in the world (1) Objective Background of VIA Methods Results Conclusions/Policy Implications